Viewing and monitoring treatment frequency and technique is important, according to Teva, as data shows that patients with asthma overestimate actual inhaler use by up to eight inhalations per week.
Patients are then able to view this data on the app, which informs patients if their inhaler technique may need improvement. The patients can choose to share these data with their healthcare ...
Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 ...
Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...
I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...